Аустралија - Енглески - APVMA (Australian Pesticides and Veterinary Medicines Authority)

ancom australia pty. limited - disodium methylarsonate = dsma - unknown - disodium methylarsonate = dsma mineral-arsenic active 0.0 - active constituent

Аустралија - Енглески - APVMA (Australian Pesticides and Veterinary Medicines Authority)

david gray & co. pty limited - monosodium methylarsonate - unknown - monosodium methylarsonate mineral-arsenic active 0.0 - active constituent

Аустралија - Енглески - APVMA (Australian Pesticides and Veterinary Medicines Authority)

amgrow pty ltd - disodium methylarsonate = dsma - unknown - disodium methylarsonate = dsma mineral-arsenic active 0.0 - active constituent

Ирска - Енглески - HPRA (Health Products Regulatory Authority)

boehringer ingelheim ltd - attenuated live bacteria lawsonia intracellularis (ms b3903) - lyophilisate + solvent for suspension - unknown - lawsonia vaccine - porcine - immunological - live vaccine

Велика Британија - Енглески - VMD (Veterinary Medicines Directorate)

boehringer ingelheim limited - lawsonia intracellularis - oral lyophilisate - live bacterial vaccine - pigs

Ирска - Енглески - HPRA (Health Products Regulatory Authority)

boehringer ingelheim ltd - attenuated live bacteria lawsonia intracellularis (ms b3903) - lyophilisate + solvent for suspension - 1x10^4.9 to 1x10^6.1 tissue culture infective dose 50/dose - lawsonia - pigs - immunological - live vaccine

Велика Британија - Енглески - VMD (Veterinary Medicines Directorate)

boehringer ingelheim animal health uk ltd - lawsonia intracellularis - oral lyophilisate - live bacterial vaccine - pigs

Сједињене Америчке Државе - Енглески - NLM (National Library of Medicine)

profounda, inc. - miltefosine (unii: 53ey29w7ec) (miltefosine - unii:53ey29w7ec) - miltefosine 50 mg - impavido (miltefosine) capsules are indicated in adults and pediatric patients 12 years of age and older weighing greater than or equal to 30 kg (66 lbs) for the treatment of: limitations of use: impavido is contraindicated in patients who are pregnant. based on animal data, miltefosine may cause fetal harm. [see boxed warning, warnings and precautions (5.1) and use in specific populations (8.1)]. impavido is contraindicated in patients who have sjögren-larsson-syndrome [see clinical pharmacology (12.3)] . impavido is contraindicated in patients who are hypersensitive to miltefosine or any impavido excipients. pregnancy exposure registry there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to impavido during pregnancy. healthcare providers are encouraged to register patients by calling 1-866-588-5405. risk summary impavido is contraindicated during pregnancy. based on data from animal reproduction studies, impavido may cause embryo-fetal toxicity when administered to pre

Сједињене Америчке Државе - Енглески - NLM (National Library of Medicine)

plymouth healthcare products llc - nickel sulfate (unii: 4flt4t3wun) (nickel cation - unii:ois2cxw7am), potassium bromide (unii: osd78555zm) (bromide ion - unii:952902ix06), sodium bromide (unii: lc1v549nom) (bromide ion - unii:952902ix06), zinc sulfate anhydrous (unii: 0j6z13x3wo) (zinc cation - unii:13s1s8sf37), sulfur (unii: 70fd1kfu70) (sulfur - unii:70fd1kfu70) - nickel sulfate 1 [hp_x] - acunol™ is indicated for the treatment of mild to moderate acne vulgaris, acne rosacea, peri-oral dermatitis, and folliculitis. it has been found to work well with a variety of combination therapies. although there are no known contraindications, patients who are allergic to any acunol™ ingredient should consult a physician prior to taking the medication. (refer to section on hypersensitivity)

Сједињене Америчке Државе - Енглески - NLM (National Library of Medicine)

nucare pharmaceuticals,inc. - silver sulfadiazine (unii: w46jy43ejr) (sulfadiazine - unii:0n7609k889) - silver sulfadiazine 10 mg in 1 g - silver sulfadiazine cream, usp 1% is a topical antimicrobial drug indicated as an adjunct for the prevention and treatment of wound sepsis in patients with second and third degree burns. silver sulfadiazine cream, usp 1% is contraindicated in patients who are hypersensitive to silver sulfadiazine or any of the other ingredients in the preparation.      because sulfonamide therapy is known to increase the possibility of kernicterus, silver sulfadiazine cream, usp 1% should not be used on pregnant women approaching or at term, on premature infants, or on newborn infants during the first 2 months of life. geriatric use. of the total number of subjects in clinical studies of silver sulfadiazine cream, usp 1% seven percent were 65 years of age and over. no overall differences in safety or effectiveness were observed between these subjects and younger subjects, and other reported clinical experience has not identified differences in responses between the elderly and younger patients, but greater se